{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:00:23Z","timestamp":1773154823874,"version":"3.50.1"},"reference-count":46,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T00:00:00Z","timestamp":1350432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Nitrofurantoin has been in use since 1953 as an effective agent for the prevention of recurrent urinary tract infection. It is associated with a wide range of adverse drug reactions. Chronic active hepatitis has increasingly been observed and many cases have been reported with case fatalities. We present a case of nitrofurantoin induced chronic active hepatitis and briefly review the serology and clinico pathological features of 57 similar cases reported in English literature. The consistent presence of antinuclear antibody, anti smooth muscle antibody, elevated immunoglobulin and pathological feature suggests an immunologic mechanism. Complete recovery is possible in most cases if medication is discontinued in time. Steroids may play a role in management if no improvement occurs despite discontinuation of medication. We suggest all patients who are on prolonged nitrofurantoin therapy be followed up with anti nuclear antibody, anti smooth muscle antibody, serum immunoglobulin and hepatic panel every three months.<\/jats:p>","DOI":"10.4081\/cp.2012.e83","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T14:22:42Z","timestamp":1350483762000},"page":"e83","source":"Crossref","is-referenced-by-count":18,"title":["Autoimmune Hepatitis Induced by Nitrofurantoin. The Importance of the Autoantibodies for an Early Diagnosis of Immune Disease"],"prefix":"10.3390","volume":"2","author":[{"given":"Jagannath M.","family":"Sherigar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minsheng","family":"Zuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Arsura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2012,10,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(74)90379-1","article-title":"Nitrofurantoin-induced pulmonary fibrosis and lupus syndrome","volume":"1","author":"Back","year":"1974","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.0954-6820.1975.tb04889.x","article-title":"Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin, Report of three cases","volume":"197","author":"Selroos","year":"1975","journal-title":"Acta Med Scand"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/00365521.1975.12097003","article-title":"Anicteric liver damage during nitrofurantoin medication","volume":"10","author":"Klemola","year":"1975","journal-title":"Scand J Gastroenterol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/bmj.4.5988.77","article-title":"Trigger factors and HLA antigens in chronic active hepatitis","volume":"4","author":"Lindberg","year":"1975","journal-title":"Br Med J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.0954-6820.1976.tb06724.x","article-title":"A nitrofurantoin-induced disorder simulating chronic active hepatitis. A case report","volume":"199","author":"Fagrell","year":"1976","journal-title":"Acta Med Scand"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/bmj.2.6028.174-b","article-title":"Letter: Chronic active hepatitis induced by nitrofurantoin","volume":"2","author":"Str\u00f6mberg","year":"1976","journal-title":"Br Med J"},{"key":"ref7","first-page":"1291","article-title":"Nitrofurantoin induced chronic active hepatitis","volume":"76","author":"Marsidi","year":"1979","journal-title":"Gastroenterology"},{"key":"ref8","first-page":"497","article-title":"Nitrofurantoin-induced chronic liver disease. Clinical course and outcome of five cases","volume":"14","author":"Iwarson","year":"1979","journal-title":"Scand J Gastroenterol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0002-9343(79)90086-X","article-title":"Nitrofurantoin: another cause of drug-induced chronic active hepatitis? A report of a patient with HLA-B8 antigen","volume":"67","author":"Hatoff","year":"1979","journal-title":"Am J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-92-1-14","article-title":"Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin","volume":"92","author":"Sharp","year":"1980","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.7326\/0003-4819-92-1-62","article-title":"Nitrofurantoin-induced chronic active hepatitis","volume":"92","author":"Black","year":"1980","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/0003-4819-97-3-452_1","article-title":"Nitrofurantoin and chronic active hepatitis","volume":"97","author":"Miller","year":"1982","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/22953337.1984.11718986","article-title":"Chronic active hepatitis due to hydroxymethylnitrofurantoin in a male patient","volume":"39","author":"Baetens","year":"1984","journal-title":"Acta Clin Belg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3949\/ccjm.52.2.253","article-title":"Chronic active hepatitis induced by nitrofurantoin","volume":"52","author":"Young","year":"1985","journal-title":"Cleve Clin Q"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5694\/j.1326-5377.1992.tb139795.x","article-title":"Hepatitis due to nitrofurantoin","volume":"156","author":"Mollison","year":"1992","journal-title":"Med J Aust"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/0016-5085(92)90783-U","article-title":"Combined nitrofurantoin toxicity to liver and lung","volume":"102","author":"Reinhart","year":"1992","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00007890-199502000-00029","article-title":"Reversible nitrofurantoin-induced chronic active hepatitis and hepatic cirrhosis in a patient awaiting liver transplantation","volume":"59","author":"Burgert","year":"1995","journal-title":"Transplantation"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9629(15)40536-1","article-title":"Nitrofurantoin-induced immune-mediated lung and liver disease","volume":"317","author":"Schattner","year":"1999","journal-title":"Am J Med Sci"},{"key":"ref19","first-page":"382","article-title":"Fatal liver necrosis associated with the use of nitrofurantoin","volume":"3","author":"Edoute","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"ref20","first-page":"184","article-title":"Nitrofurantoin-induced chronic active hepatitis","volume":"4","author":"Amit","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1345\/aph.1H136","article-title":"Nitrofurantoin-induced fulminant hepatitis mimicking autoimmune hepatitis","volume":"40","author":"Peedikayil","year":"2006","journal-title":"Ann Pharmacother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1752-1947-1-59","article-title":"Concomitant pulmonary and hepatic toxicity secondary to nitrofurantoin: a case report","volume":"1","author":"Peall","year":"2007","journal-title":"J Med Case Rep"},{"key":"ref23","first-page":"56","article-title":"Nitrofurantoin-induced chronic active hepatitis: in an elderly woman","volume":"52","author":"Galperin","year":"2007","journal-title":"SMJ"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0016-5085(19)35075-9","article-title":"Jaundice due to nitrofurantoin","volume":"41","author":"Ernaelsteen","year":"1961","journal-title":"Gastroenterology"},{"key":"ref25","first-page":"891","article-title":"Long-term hepatic memory for hypersensitivity to nitrofurantoin","volume":"87","author":"Paiva","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/096032718600500611","article-title":"Seventh-nerve palsy and hepatitis associated with nitrofurantoin","volume":"5","author":"Thomson","year":"1986","journal-title":"Hum Toxicol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0016-5085(19)34239-8","article-title":"Liver disease due to nitrofurantoin","volume":"53","author":"Jokela","year":"1967","journal-title":"Gastroenterology"},{"key":"ref28","first-page":"278","article-title":"Nitrofurantoin-induced cholestatic hepatitis from Cow's milk in a teenage boy","volume":"140","author":"Berry","year":"1984","journal-title":"West J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archinte.1975.00330050107019","article-title":"Cholestatic hepatitis after administration of furan derivatives","volume":"135","author":"Engel","year":"1975","journal-title":"Arch Intern Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005176-199310000-00013","article-title":"Fatal Choletatic hepatitis and multisystem failure associated with nitrofurantoin","volume":"17","author":"Milberg","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MAJ.0b013e31816c43a4","article-title":"Acute kindney injury, hepatitis and CPK elevation associated with Nitrofurantoin therapy","volume":"337","author":"Beigel","year":"2009","journal-title":"Am J med Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00002018-199615010-00007","article-title":"Antibacterial-induced hepatotoxicity. Incidence, prevention and management","volume":"15","author":"George","year":"1996","journal-title":"Drug Saf"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0002-9343(80)90443-X","article-title":"Adverse reactions to nitrofurantoin: analysis of 921 reports","volume":"69","author":"Holmberg","year":"1980","journal-title":"Am J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840080327","article-title":"Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases","volume":"8","author":"Stricker","year":"1988","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in drug-induced liver disease","volume":"62","author":"Ramachandran","year":"2009","journal-title":"J Clin Pathol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0009-2797(77)90131-4","article-title":"Cytotoxicity and DNA damage to mammalian cells by nitrofurans","volume":"16","author":"Olive","year":"1977","journal-title":"Chem Biol Interact"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0300-5089(21)00216-9","article-title":"Hepatotoxicity: pathogenesis and therapeutic intervention","volume":"8","author":"Black","year":"1979","journal-title":"Clin Gastroenterol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-3083.1976.tb00276.x","article-title":"Immuni-electrophoretic \u201ctailing\u201d of albumin line due to albumin-IgG antibody complexus: a side effect of nitrofurantoin treatment?","volume":"5","author":"Teppo","year":"1976","journal-title":"Scand J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0168-8278(94)80004-9","article-title":"Possible role of HLA in hepatotoxicity: an exploratory study in 71 patients with drug-induced idiosyncratic hepatitis","volume":"20","author":"Berson","year":"1994","journal-title":"J Hepatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornson","year":"2010","journal-title":"Hepatology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1752-1947-4-311","article-title":"Autoimmune hepatitis triggered by nitrofurantoin: a case series","volume":"4","author":"Appleyard","year":"2010","journal-title":"J Med Case Rep"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2298\/VSP1206536M","article-title":"Nitrofurantoin-induced immune-mediated lung and liver disease","volume":"69","author":"Milic","year":"2012","journal-title":"Voinosanit Pregl"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2011.02.024","article-title":"Drug induced liver injury and its relationship to autoimmune hepatitis","volume":"55","author":"Weiler-Normann","year":"2011","journal-title":"J Hepatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0049-0172(99)80004-3","article-title":"Minocycline-induced autoimmune syndromes: an overview","volume":"28","author":"Elkayam","year":"1999","journal-title":"Semin Arthritis Rheumat"}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/2\/4\/e83\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T06:18:25Z","timestamp":1644473905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/2\/4\/e83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,17]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,12]]}},"alternative-id":["cp.2012.e83"],"URL":"https:\/\/doi.org\/10.4081\/cp.2012.e83","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,17]]}}}